Gurnet Point Capital
Pre-Seed–Late Stage · 3 people tracked
Investment thesis
B-FLEXION invests across transformative industries with a particular focus on life sciences. The firm conducts seed investments, acquires operating businesses, and develops strategic partnerships while maintaining a dedicated practice for biopharma, diagnostics, and innovative healthcare service providers.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from curated
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Data & Infrastructure ×1Digital Health ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathNaveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US
James McNally(Executive Officer, Director)Piyush Gupta(Executive Officer, Director)
BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)
Frequently asked questions
- What stage does Gurnet Point Capital invest at?
- Gurnet Point Capital invests at the Pre-Seed, Seed, Late Stage stages.
- What sectors does Gurnet Point Capital focus on?
- Gurnet Point Capital focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
Abstract is a San Francisco-based venture capital firm managing $1.8 billion in assets, investing in seed and early-stage companies across all sectors.